Complement-Based Drug Development Summit leaderboard
  • Monday, August 24, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 222

Author

Pharma Journalist 9017 posts 0 comments

CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics

Dec 13, 2022
CSL Limited announced that its subsidiary, CSL Seqirus, finalized its global collaboration and license agreement with Arcturus Therapeutics Holdings Inc (“Arcturus Therapeutics”;…
Read More...

Registration is now open for the 4th Annual AI in Drug Discovery Conference

Dec 13, 2022
SAE Media Group reports: The brochure is available to download for the 4th Annual AI in Drug Discovery Conference in London. SAE Media Group is proud to present the return of the AI…
Read More...

HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based…

Dec 12, 2022
Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. ("Nitrase"), a biopharmaceutical company…
Read More...

Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage…

Dec 12, 2022
Kite, a Gilead Company and Arcellx, Inc. announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for the…
Read More...

Sobi Receives Approval from Health Canada for Empaveli (pegcetacoplan) for the Treatment of Certain…

Dec 12, 2022
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that Health Canada has approved Empaveli™ (pegcetacoplan), a complement inhibitor, for the…
Read More...

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted…

Dec 9, 2022
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
Read More...

Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape…

Dec 9, 2022
Vertex Pharmaceuticals Incorporated and Entrada Therapeutics, Inc. announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™)…
Read More...

Reuters Events Digital Health event returns to California to help empower clinicians, engage…

Dec 9, 2022
300+ C-suite and board level leaders from NYU Langone, Sutter Health, Memorial Hermann, UCI Health and others will unite in San Diego on May 16-17, to force radical change over two…
Read More...

Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH

Dec 8, 2022
Akero Therapeutics, Inc. a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced that…
Read More...

VBI Vaccines Announces Health Canada Approval for PreHevbrio for the Prevention of Hepatitis B in…

Dec 8, 2022
VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that Health Canada has approved PreHevbrio…
Read More...
Prev Next
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Piramal Pharma Takes Majority Stake in Yapan Bio
  • Charles River and Medigen Partner on Next-Generation Enterovirus Vaccine
  • WellSpan and Johns Hopkins Expand Cancer Care Collaboration
  • SandboxAQ Launches AI Model to Speed Drug Discovery
  • FDA Approves Ultragenyx Gene Therapy for Rare GSDIa Disorder

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.